Achieve Life Sciences Inc. (ACHV) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Achieve Life Sciences Inc...

    NASDAQ: ACHV · Real-Time Price · USD
    2.83
    0.04 (1.43%)
    At close: Sep 05, 2025, 3:59 PM
    2.85
    0.53%
    After-hours: Sep 05, 2025, 07:37 PM EDT

    Achieve Life Sciences Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 229K 228K 236K 250K
    Gross Profit
    		 -229K -228K -236K -250K
    Operating Income
    		 -39.07M -27.25M -40.8M -33.09M
    Interest Income
    		 2.36M 825K 199K 17K
    Pretax Income
    		 -39.83M -29.82M -42.35M -33.15M
    Net Income
    		 -39.83M -29.82M -41.88M -32.9M
    Selling & General & Admin
    		 16.25M 11.44M 10.72M 9.13M
    Research & Development
    		 22.82M 15.81M 30.08M 23.97M
    Other Expenses
    		 -229K n/a n/a -58K
    Operating Expenses
    		 38.84M 27.02M 40.8M 33.09M
    Interest Expense
    		 2.18M 2.85M 1.79M n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 39.07M 27.25M 40.8M 33.09M
    Income Tax Expense
    		 n/a n/a -475K -250K
    Shares Outstanding (Basic)
    		 32.07M 19.83M 10.59M 8.12M
    Shares Outstanding (Diluted)
    		 32.07M 19.83M 10.59M 8.12M
    EPS (Basic)
    		 -1.24 -1.5 -3.95 -4.05
    EPS (Diluted)
    		 -1.24 -1.5 -3.95 -4.05
    EBITDA
    		 -37.42M -26.73M -40.33M -32.9M
    EBIT
    		 -37.65M -26.96M -40.56M -33.15M
    Depreciation & Amortization
    		 229K 228K 236K 250K

    Add to Watchlist